Kaplan–Meier’s overall survival plot for CRC patients based on MAPK8IP2 expression revealed a significant decrease (p < 0.001) in survival for colorectal patients with a higher expression of MAPK8IP2. This evidence concerns the gene MAPK8IP2 and colorectal carcinoma.